BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260318T140000
DTEND;TZID=America/New_York:20260318T160000
DTSTAMP:20260403T232835
CREATED:20260129T164647Z
LAST-MODIFIED:20260317T164914Z
UID:2881-1773842400-1773849600@lifescievents.com
SUMMARY:Annexon In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
DESCRIPTION:Join Annexon for an in-person and virtual key opinion leader (KOL) event to provide an overview of geographic atrophy (GA)\, an advanced form of dry\, age-related macular degeneration (AMD) of the retina\, featuring GA experts: \n\nEleonora (Nora) Lad\, MD\, PhD – Vice Chair of Ophthalmology Clinical Research\, Duke University Medical Center\nCharlie Wykoff\, MD\, PhD – Retina Specialist\, Retina Consultants of Texas; Chair of Clinical Trials\, Retina Consultants of America\n\nPresentations from GA experts and Annexon will highlight: \n\nThe unmet need and current treatment landscape for GA\nThe mechanism of disease and role of C1q\nVonaprument\, Annexon’s neuroprotective C1q inhibitor with potential to be the first targeted vision-preserving therapy for GA\nAnnexon’s pivotal Phase 3 ARCHER II trial expected to read out in the second half of this year\n\nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/hl0snwj7/.
URL:https://lifescievents.com/event/hl0snwj7/
LOCATION:Midtown\, New York and Live Webcast\, Midtown\, New York and Live Webcast
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/01/Annexon-Banner-1.png
END:VEVENT
END:VCALENDAR